Psychological Characteristics of Patients With Severe Asthma (CATAPLASTHMA)

Centre Hospitalier Universitaire de Besancon

Status

Enrolling

Conditions

Personality Trait

Asthma

Coping Skills

Attachment

Treatments

Other: Questionnaires

Study type

Interventional

Funder types

Other

Identifiers

NCT05739708

2022/727

Details and patient eligibility

About

Like any chronic disease, asthma exposes individuals to stressful and threatening situations that require ongoing cognitive, emotional, behavioral and social adaptation. Approximately 5-10% of patients with asthma have a treatment-resistant disease, with frequent emergency room visits and hospitalizations. These patients are responsible for the majority of the overall asthma-related disease burden and also represent more than half of the total direct costs of asthma management. The scientific literature shows that personality traits, attachment type and psychological disorders will significantly influence disease coping strategies, disease experience, quality of life, adherence and therapeutic alliance. Although some data exist in asthma, there are currently no studies that have evaluated the overall psychological profile of asthma patients, and we have no data specifically on the population of severe asthmatics, who are the most difficult to manage. A better understanding of the overall psychological dimension of asthma patients will make it possible to offer therapeutic education programs that are more targeted according to the psychosocial skills of the patient and finally improve the overall management of the disease.

Enrollment

150 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patient aged ≥ 18 years and followed in the Respiratory Department of the Besançon University Hospital for an asthmatic disease diagnosed for more than 12 months. Will be considered as severe patients, asthma patients with uncontrolled asthma despite high therapeutic pressure (GINA levels 4 and 5) and patients requiring to be controlled high doses of inhaled corticosteroids and long-acting beta-2-agonists (or anti-leukotriene/theophylline) in the past year or systemic corticosteroid therapy (>50% in the previous year) (ATS-ERS 2014 criteria).
Patient able to understand the objectives of the research
Patient who has signed a research consent form
Patient affiliated to a French social security system or beneficiary of such a system

Exclusion criteria

Patient with reading and comprehension difficulties that prevent them from completing the questionnaires
Motor disability that prevents the patient from completing the questionnaires
Legal incapacity or limited legal capacity
Subject unlikely to cooperate with the study and/or poor cooperation anticipated by the the investigator
Subject without health insurance
Subject under court protection, guardianship, conservatorship, or protective supervision. protection.